Clinical evidence that stands up to scrutiny
We search, screen, appraise and synthesize published clinical evidence, and plan the surveillance and safety systems that follow. We do not run trials or act as a CRO.
What we do
What we prepare for clinical evidence teams
Each item links to a service page with deliverables, inputs and boundaries. We prepare technical evidence, plans and strategy. We do not certify products, approve submissions or give legal opinions.
Systematic review and meta-analysis
Protocol, dual screening, risk-of-bias appraisal and pooling where the data allow, reported to PRISMA 2020 with GRADE certainty ratings.
Systematic reviewsClinical evaluation literature review
A reproducible search, appraisal and state-of-the-art summary for the clinical evaluation of a medical device under EU MDR.
Clinical evaluationPost-market surveillance
Scheduled literature surveillance that feeds your PMS reports, and a literature component for post-market clinical follow-up plans.
Post-market surveillancePharmacovigilance
Safety system and PSMF design, vendor selection and oversight criteria, and scheduled signal screening. We do not serve as your QPPV.
PharmacovigilanceCompetitive intelligence
Tracking of competing programs through trial registries, publications and pipelines, with scientist-verified monthly digests.
Competitive intelligenceTarget product profile
Turn a clinical need into minimum and target product attributes, mapped to the evidence and tests that would support each one.
Target product profileWe work with published and public evidence. Study conduct, monitoring and data management stay with your CRO or clinical team.
Illustrative situations
Problems we are typically asked to solve
These describe typical client types and problems. They are not client results, and we cannot promise outcomes, approvals or timelines.
Does an intervention improve outcomes? Ask the literature first
Research consortium. A consortium wants to know whether antimicrobial dressings improve wound healing before committing to a new study.
How we advise. We define the question (PICO), write and register the protocol, screen in duplicate, appraise risk of bias, pool where the studies allow and grade certainty.
You receive. A protocol, search strategies, evidence tables and a PRISMA 2020 report.
An auditor questions the literature search
Medical device manufacturer. The literature review in a technical file cannot be reproduced, and an auditor has asked how the search was run.
How we advise. We rebuild the search from a documented protocol, screen and appraise the results, and help you draft a factual response.
You receive. A documented search, an updated literature section and response notes.
Do complaints match what the literature reports?
Marketed device company. A complaint trend has appeared, and the team wants to know whether published reports describe the same problem.
How we advise. We screen literature and public adverse-event databases and state clearly that report counts are not incidence.
You receive. A short memo with sources, caveats and suggested follow-up questions.
Describe your clinical evidence question
Send a general description of the problem and your deadline. A scientist follows up by email and prepares a written quote once the scope is clear.